Volume 5, Issue 9-10

2018pp 252—268

About the Cover

The cover for this issue of Oncoscience features Figure 1 ("TP53 mutation status: emerging biomarker for precision radiation medicine?") from Willers et al.

Research Perspectives

Re-thinking preclinical models of cancer metastasis

Maria F. Ullo, Jeremy S. Logue

https://doi.org/10.18632/oncoscience.450pp 252—253

PDF Full-Text

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance

Shailender S. Chauhan, Noel A. Warfel

https://doi.org/10.18632/oncoscience.458pp 254—255

PDF Full-Text

Risks and chances of aberrant DNA repair in cancer

Maria Schubert, Richard Greil, Rol Geisberger

https://doi.org/10.18632/oncoscience.459pp 256—257

PDF Full-Text

TP53 mutation status: emerging biomarker for precision radiation medicine?

Henning Willers, Meng Wang, Cyril H. Benes

https://doi.org/10.18632/oncoscience.468pp 258—259

PDF Full-Text

ETV4: an emerging target in pancreatic cancer

Sachin Kumar Deshmukh, Ajay P. Singh, Seema Singh

https://doi.org/10.18632/oncoscience.471pp 260—261

PDF Full-Text

Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018)

Marta Díaz-Martínez, Lucía Benito-Jardón, Lola Alonso, Joaquin Teixidó

https://doi.org/10.18632/oncoscience.473pp 262—263

PDF Full-Text

Research Papers

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment

Dana C. Galván, Anoop P. Ayyappan, Brad A. Bryan

https://doi.org/10.18632/oncoscience.472pp 264—268

View Abstract PDF Full-Text